Navigation Links
Vicriviroc Demonstrates Potent and Sustained Viral Suppression Through 48 Weeks of Therapy in Treatment-Experienced HIV-Infected Patients
Date:2/6/2008

regardless of the number of active HIV drugs in a patient's background therapy."

The study, known as VICTOR-E1 (Vicriviroc in Combination Treatment with Optimized Antiretroviral Therapy Regimen in Experienced Subjects), evaluated the safety and efficacy of vicriviroc (30 mg or 20 mg once daily) in combination with an optimized ritonavir-boosted, protease inhibitor-containing antiretroviral regimen compared to a control group receiving new OBT alone. The primary endpoint of the study was change in HIV-RNA at week 48. A total of 116 treatment-experienced adult HIV-infected patients with R5-type virus at screening were randomized in this placebo-controlled, double-blind study at 37 sites throughout Europe, South Africa and North and South America.

Results of the study through 48 weeks demonstrated potent and sustained viral suppression in the vicriviroc arms, with significantly greater decreases in mean HIV-RNA, as well as greater increases in mean CD4 counts, compared to the control arm. At 48 weeks, patients in the 30 mg and 20 mg vicriviroc treatment groups achieved mean decreases from baseline in viral load of -1.77 and -1.75 (log10 copies/mL), respectively, compared to -0.79 for the control group (p=0.0017 and p=0.0026, respectively). Mean increases from baseline in CD4 cell counts in the vicriviroc groups were +102 and +134 (cells/mm3), respectively, compared to +65 in the control group. Fewer patients in the vicriviroc groups discontinued from the study due to virologic failure compared to those in the control group (13 percent and 8 percent vs. 38 percent, respectively).

No clinically relevant differences in safety profile between the vicriviroc and control groups were observed in this study, including liver toxicity, opportunistic infections, malignancies or other conditions. There were no cases of grade 3/4 elevated ALT reported in the vicriviroc groups compared to one case in the control group, and there were one, two and one cases of g
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds
2. Study Demonstrates Marteks Algal DHA Oil Improves Blood Triglyceride Lipid Levels
3. Highmarks Hospital Pay-for-Performance Program Demonstrates Impressive Results
4. Facet Solutions AFRS(TM) Implant Demonstrates Positive Clinical Results After One Year Follow Up
5. LIALDA demonstrates prolonged release of mesalamine in an in vitro study using a simulated colon
6. ENDEAVOR IV achieves primary endpoint, demonstrates similar safety profile compared to Taxus stent
7. New Study Data Published in British Journal of Urology Demonstrates Cryoablation Effective for Kidney Cancer
8. Data Show SuperGens Multi-Targeted Tyrosine Kinase Inhibitor Demonstrates Pre-clinical Activity in Glioblastoma Multiforme
9. First in the World Live Case Using New Technology Demonstrates Shorter Procedure Time
10. Study Shows Organons Asenapine Demonstrates Efficacy and Tolerability in Treating Acute Schizophrenia
11. US Preventive Medicine(R) Says Study on Heart Disease-related Deaths Demonstrates Need for Preventive Medical Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... MA (PRWEB) October 22, 2014 ... new solutions for the treatment of bacterial infections, microbial ... Sinskey has joined its board of directors. , ... and Engineering Systems at The Massachusetts Institute of Technology, ... MIT faculty since 1968. Dr. Sinskey also holds positions ...
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. 21, 2014 ... lead to increased blood pressure, according to a new study. ... blood pressure for young adult women or for teenagers, according ... lightly or moderately, their risk of high blood pressure was ... studies in older adult men and women," said lead researcher ...
(Date:10/22/2014)... Dennis Thompson HealthDay Reporter ... who was diagnosed with Ebola while working for NBC News ... can leave the special isolation unit at Nebraska Medical Center in ... the hospital said Tuesday. A blood test confirmed by the ... 33, can head home to Providence, R.I., NBC News ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 The ... a booth at the American Foundation for Suicide Prevention’s ... The AFSP is a not-for-profit organization that hosts hundreds ... proceeds from these events are used to help understand ... education and personal relationships as well. , The ...
(Date:10/20/2014)... 20, 2014 hc1.com today announced ... cloud solution that enables healthcare organizations of all ... healthcare-specific customer relationship management (“CRM”) solution. , Designed ... needs of the healthcare industry, the hc1 Healthcare ... and patients by combining healthcare CRM, HIPAA-compliant collaboration, ...
Breaking Medicine News(10 mins):Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Binge Drinking May Boost Blood Pressure in Young Men 2Health News:Binge Drinking May Boost Blood Pressure in Young Men 3Health News:Binge Drinking May Boost Blood Pressure in Young Men 4Health News:U.S. Cameraman Treated for Ebola 'Free' of the Virus 2Health News:U.S. Cameraman Treated for Ebola 'Free' of the Virus 3Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 2Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 3Health News:Healthcare Relationship Management (HRM) Leader hc1.com® Launches hc1® Quick Start™ 2
... Atlantium Technologies, an Israeli-based water technologies company, today ... light water pasteurization and disinfection systems are now ... the U.S. dairy industry. The announcement by ... Administration finalized the 2009 Pasteurized Milk Ordinance (PMO), ...
... BRIDGEWATER, N.J., Oct. 15 In support of National ... new initiative to expand its commitment to raising awareness ... is sharing findings from the GRACE (Gender, Race And ... in North American women previously treated with HIV medications ...
... continued effort to give back to the communities in ... Fairfax, Va.-based American Society for Radiation Oncology (ASTRO) is ... cancer survivorship. Halos of Hope will work with ... ASTRO,s 51st Annual Meeting, scheduled for November 1-5, 2009, ...
... give back to the communities in the cities visited ... Radiation Oncology (ASTRO) is partnering with Gilda,s Club Chicago ... Chicago will work with ASTRO by participating in the ... for November 1-5, 2009, at McCormick Place West in ...
... , CHICAGO, Oct. 15 The NFL and National Dairy ... new initiative aimed at tackling childhood obesity by giving youth ... environment. The program will reach 36 million youth in 60,000 ... , The youth-led program empowers children and teens to take ...
... , MORRISVILLE, Pa., Oct. 15 Managing Myeloma ... educational website for multidisciplinary professionals, announces the opportunity for ... the December 2009 American Society of Hematology Annual Meeting ... airfare, hotel accommodations, and a per diem ...
Cached Medicine News:Health News:Atlantium Technologies' UV System Provides U.S. Dairy Processors With the Equivalent to Heat-Pasteurized Water 2Health News:Atlantium Technologies' UV System Provides U.S. Dairy Processors With the Equivalent to Heat-Pasteurized Water 3Health News:Tibotec Therapeutics Recognizes National Latino AIDS Awareness Day With Information and Insights for the Latino Community 2Health News:Tibotec Therapeutics Recognizes National Latino AIDS Awareness Day With Information and Insights for the Latino Community 3Health News:Tibotec Therapeutics Recognizes National Latino AIDS Awareness Day With Information and Insights for the Latino Community 4Health News:Tibotec Therapeutics Recognizes National Latino AIDS Awareness Day With Information and Insights for the Latino Community 5Health News:Tibotec Therapeutics Recognizes National Latino AIDS Awareness Day With Information and Insights for the Latino Community 6Health News:Tibotec Therapeutics Recognizes National Latino AIDS Awareness Day With Information and Insights for the Latino Community 7Health News:NFL, National Dairy Council Take Aim at Childhood Obesity With Fuel Up to Play 60 2Health News:NFL, National Dairy Council Take Aim at Childhood Obesity With Fuel Up to Play 60 3Health News:NFL, National Dairy Council Take Aim at Childhood Obesity With Fuel Up to Play 60 4Health News:NFL, National Dairy Council Take Aim at Childhood Obesity With Fuel Up to Play 60 5Health News:Managing Myeloma Website Announces Fellow Scholarship Program to Attend and Report on Annual American Society of Hematology in New Orleans 2
(Date:10/22/2014)... Calif., Oct. 21, 2014 Abaxis, Inc. (NasdaqGS: ... point-of-care blood analysis systems, today reported financial results for ... Second quarter overview: , Revenues of $53.9 ... , Diluted EPS of $0.24, up 33% over last ... Service revenues from Abaxis Veterinary Reference Laboratories (AVRL) of ...
(Date:10/22/2014)... 22, 2014 Sanomedics International Holdings, Inc. (OTCQB: ... Global Research & Data Services, demand for thermometers is ... through 2018, as demand for more accurate digital thermometers ... the world,s largest market for thermometers, and one of ... Sanomedics International Holdings, Inc. Sanomedics International Holdings ...
(Date:10/22/2014)... 2014  AcelRx Pharmaceuticals, Inc. (NASDAQ: ... IAP310 study have been published in Regional ... journal with broad, multidisciplinary readership. IAP310 was a ... and efficacy of Zalviso, also referred to as ... treatment of post-operative pain in patients following open ...
Breaking Medicine Technology:Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 2Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 3Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 4Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 5Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 6Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 7Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 8Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 9Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 10Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 11Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 12Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 13Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 14Sanomedics International Holdings Analyst Report: Taking Some Heat by BrokerBank Securities, Inc. 2AcelRx Announces Publication of Zalviso Phase 3 Abdominal Trial Results 2
... announced on August 23 the appointment of Dr. Jennifer Choo ... B.V. Dr. Choo will oversee the company,s Rose K business ... growing specialty lens portfolio. For the last 3 ... Inc. and the Brien Holden Vision Institute (BHVI) based in ...
... Therapeutics, Inc. ("CTI") (NASDAQ and MTA: CTIC) today announced ... 120 List of Outstanding Issues to the European Medicines ... Use ("CHMP") in regards to CTI,s Marketing Authorization Application ... aggressive non-Hodgkin,s lymphoma ("NHL"). With this submission, CTI expects ...
Cached Medicine Technology:Jennifer Choo Joins Menicon as Specialty Lens Clinical Manager 2Cell Therapeutics Submits Day 120 Response for Pixantrone Marketing Authorization Application to European Medicines Agency; Potential Q1 2012 Opinion on Approval 2Cell Therapeutics Submits Day 120 Response for Pixantrone Marketing Authorization Application to European Medicines Agency; Potential Q1 2012 Opinion on Approval 3
... (FSH) is a glycoprotein hormone secreted ... hCG, LH and TSH, the intact ... consisting of alpha- and beta-subunits. Its ... gonadotropin-releasing hormone (GnRH) from the hypothalamus. ...
... II Direct to High Res SSP kits provide high ... tray. Locus specific typing on a single tray reduces ... Straight from genomic DNA to high resolution results, no ... typing with a single tray , Unique reaction pattern ...
... Res SSP kits provide high resolution typing of the ... on a single tray reduces QC and testing costs ... to high resolution results, no need for initial low ... tray , Unique reaction pattern for most common alleles ...
... storage of blood plasma in full accordance ... to operating temperatures and performance means that ... freezer you will minimise bag cracking normally ... an additional benefit is reduced thawing time. ...
Medicine Products: